XML 47 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Noncontrolling Interest
Beginning balance (deficit) (in shares) at Dec. 31, 2017   22,542,672          
Beginning Balance (deficit) at Dec. 31, 2017 $ 313.1 $ 0.0 $ 254.6 $ (1.2) $ 67.0 $ (7.5) $ 0.2
Increase (Decrease) in Stockholders' Equity              
Net income 15.9       15.3   0.6
Foreign currency translation (0.4)     (0.4)      
Issuance of restricted stock units (in shares)   45,963          
Issuance of restricted stock units 0.0            
Issuance of performance stock units (in shares)   48,174          
Issuance of performance stock units 0.0            
Non-cash stock-based compensation related to restricted stock units and performance share units 0.6   0.6        
Distribution to noncontrolling interest (0.8)           (0.8)
Ending balance (deficit) (in shares) at Mar. 31, 2018   22,636,809          
Ending Balance (deficit) at Mar. 31, 2018 328.3 $ 0.0 255.2 (1.6) 82.2 (7.5) 0.0
Beginning balance (deficit) (in shares) at Dec. 31, 2017   22,542,672          
Beginning Balance (deficit) at Dec. 31, 2017 313.1 $ 0.0 254.6 (1.2) 67.0 (7.5) 0.2
Increase (Decrease) in Stockholders' Equity              
Net income 46.6            
Ending balance (deficit) (in shares) at Sep. 30, 2018   22,729,564          
Ending Balance (deficit) at Sep. 30, 2018 358.7 $ 0.0 256.7 (1.6) 111.1 (7.5) 0.0
Beginning balance (deficit) (in shares) at Mar. 31, 2018   22,636,809          
Beginning Balance (deficit) at Mar. 31, 2018 328.3 $ 0.0 255.2 (1.6) 82.2 (7.5) 0.0
Increase (Decrease) in Stockholders' Equity              
Net income 16.2       15.3   0.9
Foreign currency translation (0.2)     (0.2)      
Issuance of stock grants (in shares)   20,757          
Issuance of stock grants 0.7   0.7        
Non-cash stock-based compensation related to restricted stock units and performance share units 0.9   0.9        
Distribution to noncontrolling interest (0.8)           (0.8)
Ending balance (deficit) (in shares) at Jun. 30, 2018   22,657,566          
Ending Balance (deficit) at Jun. 30, 2018 345.2 $ 0.0 256.8 (1.8) 97.6 (7.5) 0.1
Increase (Decrease) in Stockholders' Equity              
Net income 14.5       13.5   1.0
Foreign currency translation 0.1     0.1      
Issuance of restricted stock units (in shares)   71,998          
Issuance of stock grants 0.0   0.0        
Non-cash stock-based compensation related to restricted stock units and performance share units (0.1)   (0.1)        
Distribution to noncontrolling interest (1.0)           (1.0)
Ending balance (deficit) (in shares) at Sep. 30, 2018   22,729,564          
Ending Balance (deficit) at Sep. 30, 2018 $ 358.7 $ 0.0 256.7 (1.6) 111.1 (7.5) 0.0
Beginning balance (deficit) (in shares) at Dec. 31, 2018 22,783,976 22,783,976          
Beginning Balance (deficit) at Dec. 31, 2018 $ 368.6 $ 0.0 257.7 (2.4) 120.7 (7.5) 0.1
Increase (Decrease) in Stockholders' Equity              
Net income 10.9       10.6   0.3
Foreign currency translation 0.2     0.2      
Issuance of restricted stock units (in shares)   7,518          
Issuance of restricted stock units 0.0            
Issuance of performance stock units (in shares)   62,094          
Issuance of performance stock units 0.0            
Non-cash stock-based compensation related to restricted stock units and performance share units 0.4   0.4        
Treasury stock (2.3)         (2.3)  
Distribution to noncontrolling interest (0.7)           (0.7)
Ending balance (deficit) (in shares) at Mar. 31, 2019   22,853,588          
Ending Balance (deficit) at Mar. 31, 2019 $ 377.0 $ 0.0 258.0 (2.2) 131.3 (9.8) (0.3)
Beginning balance (deficit) (in shares) at Dec. 31, 2018 22,783,976 22,783,976          
Beginning Balance (deficit) at Dec. 31, 2018 $ 368.6 $ 0.0 257.7 (2.4) 120.7 (7.5) 0.1
Increase (Decrease) in Stockholders' Equity              
Net income 42.2            
Effective portion of unrealized loss on cash flow hedge $ (0.9)            
Ending balance (deficit) (in shares) at Sep. 30, 2019 22,948,766 22,948,766          
Ending Balance (deficit) at Sep. 30, 2019 $ 378.3 $ 0.0 260.8 (3.3) 160.6 (39.8) 0.0
Beginning balance (deficit) (in shares) at Mar. 31, 2019   22,853,588          
Beginning Balance (deficit) at Mar. 31, 2019 377.0 $ 0.0 258.0 (2.2) 131.3 (9.8) (0.3)
Increase (Decrease) in Stockholders' Equity              
Net income 16.3       15.2   1.1
Foreign currency translation (0.1)     (0.1)      
Effective portion of unrealized loss on cash flow hedge (0.8)     (0.8)      
Issuance of restricted stock units (in shares)   11,745          
Issuance of restricted stock units 0.0            
Issuance of stock grants (in shares)   14,076          
Issuance of stock grants 0.5   0.5        
Non-cash stock-based compensation related to restricted stock units and performance share units 1.0   1.0        
Treasury stock (11.3)         (11.3)  
Distribution to noncontrolling interest (0.7)           (0.7)
Ending balance (deficit) (in shares) at Jun. 30, 2019   22,879,409          
Ending Balance (deficit) at Jun. 30, 2019 381.9 $ 0.0 259.5 (3.1) 146.5 (21.1) 0.1
Increase (Decrease) in Stockholders' Equity              
Net income 15.0       14.2   0.8
Foreign currency translation (0.1)     (0.1)      
Effective portion of unrealized loss on cash flow hedge (0.1)     (0.1)      
Issuance of restricted stock units (in shares)   69,357          
Issuance of restricted stock units 0.0            
Non-cash stock-based compensation related to restricted stock units and performance share units 1.3   1.3        
Treasury stock (18.7)         (18.7)  
Distribution to noncontrolling interest $ (1.0)           (1.0)
Ending balance (deficit) (in shares) at Sep. 30, 2019 22,948,766 22,948,766          
Ending Balance (deficit) at Sep. 30, 2019 $ 378.3 $ 0.0 $ 260.8 $ (3.3) $ 160.6 $ (39.8) $ 0.0